ORTHOFIX MEDICAL INC (OFIX) Stock Price, Forecast & Analysis

USA Nasdaq NASDAQ:OFIX • US68752M1080

12.96 USD
-0.49 (-3.64%)
Last: Feb 3, 2026, 02:53 PM

OFIX Key Statistics, Chart & Performance

Key Statistics
Market Cap513.22M
Revenue(TTM)818.06M
Net Income(TTM)-119.12M
Shares39.60M
Float38.64M
52 Week High20.48
52 Week Low10.24
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-1.08
PEN/A
Fwd PEN/A
Earnings (Next)02-23
IPO1992-04-24
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
OFIX short term performance overview.The bars show the price performance of OFIX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 -10

OFIX long term performance overview.The bars show the price performance of OFIX in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 -10 -20 -30

The current stock price of OFIX is 12.96 USD. In the past month the price decreased by -9.37%. In the past year, price decreased by -26.1%.

ORTHOFIX MEDICAL INC / OFIX Daily stock chart

OFIX Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

OFIX Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to OFIX. Both the profitability and financial health of OFIX have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

OFIX Financial Highlights

Over the last trailing twelve months OFIX reported a non-GAAP Earnings per Share(EPS) of -1.08. The EPS decreased by -10900% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -14.31%
ROE -26.92%
Debt/Equity 0.39
Chartmill High Growth Momentum
EPS Q2Q%-914.29%
Sales Q2Q%4.59%
EPS 1Y (TTM)-10900%
Revenue 1Y (TTM)4.31%

OFIX Forecast & Estimates

11 analysts have analysed OFIX and the average price target is 23.26 USD. This implies a price increase of 79.44% is expected in the next year compared to the current price of 12.96.

For the next year, analysts expect an EPS growth of -23152% and a revenue growth 2.31% for OFIX


Analysts
Analysts85.45
Price Target23.26 (79.48%)
EPS Next Y-23152%
Revenue Next Year2.31%

OFIX Ownership

Ownership
Inst Owners91.28%
Ins Owners1.4%
Short Float %N/A
Short RatioN/A

OFIX Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 21.06 188.61B
ISRG INTUITIVE SURGICAL INC 53.76 170.18B
SYK STRYKER CORP 26.48 138.05B
BSX BOSTON SCIENTIFIC CORP 31.02 135.64B
BDX BECTON DICKINSON AND CO 14.31 58.88B
IDXX IDEXX LABORATORIES INC 48.88 51.02B
EW EDWARDS LIFESCIENCES CORP 32.06 47.81B
RMD RESMED INC 24.54 36.82B
GEHC GE HEALTHCARE TECHNOLOGY 17.08 35.71B
DXCM DEXCOM INC 38.41 27.86B
PODD INSULET CORP 54.92 17.66B
ZBH ZIMMER BIOMET HOLDINGS INC 10.68 17.12B

Related stock screener links

About OFIX

Company Profile

OFIX logo image Orthofix Medical, Inc. engages in the provision of medical devices. The company is headquartered in Lewisville, Texas and currently employs 1,616 full-time employees. The firm offers a portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH navigation system. The Company’s Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. The segment provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. The company offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Orthopedics segment offers products and solutions for limb deformity correction and complex limb reconstruction with a focus on use in trauma, adult and pediatric limb reconstruction, and foot and ankle procedures.

Company Info

ORTHOFIX MEDICAL INC

3451 Plano Pkwy

Lewisville TEXAS 75056 US

CEO: Jon Serbousek

Employees: 1616

OFIX Company Website

OFIX Investor Relations

Phone: 12149372000

ORTHOFIX MEDICAL INC / OFIX FAQ

Can you describe the business of ORTHOFIX MEDICAL INC?

Orthofix Medical, Inc. engages in the provision of medical devices. The company is headquartered in Lewisville, Texas and currently employs 1,616 full-time employees. The firm offers a portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH navigation system. The Company’s Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. The segment provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. The company offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Orthopedics segment offers products and solutions for limb deformity correction and complex limb reconstruction with a focus on use in trauma, adult and pediatric limb reconstruction, and foot and ankle procedures.


What is the stock price of ORTHOFIX MEDICAL INC today?

The current stock price of OFIX is 12.96 USD. The price decreased by -3.64% in the last trading session.


What is the dividend status of ORTHOFIX MEDICAL INC?

OFIX does not pay a dividend.


What is the ChartMill technical and fundamental rating of OFIX stock?

OFIX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


On which exchange is OFIX stock listed?

OFIX stock is listed on the Nasdaq exchange.


Who owns ORTHOFIX MEDICAL INC?

You can find the ownership structure of ORTHOFIX MEDICAL INC (OFIX) on the Ownership tab.